FDA

Novel tool to detect fake and sub-standard Malaria Treatment

Novel tool to detect fake and sub-standard Malaria Treatment

According to official data, over 200 million people get affected by malaria and especially in Asia and Africa. The disease, which gets spread through the infected female Anopheles mosquito bite, kills more than 660,000 people across the globe every year.

Companies: 

Breo Receives Good Initial Review from FDA

Breo Receives Good Initial Review from FDA

Manufactured by GlaxoSmithKline Plc. and Theravance Inc., Breo is an inhaled treatment for chronic obstructive pulmonary disease (COPD). The treatment has got positive review initially from the US Food and Drug Administration (FDA).

General: 
Companies: 

Drug Used by MS Patients for Walking May Also Help Stroke’s Patients

Drug Used by MS Patients for Walking May Also Help Stroke’s Patients

As per a press releases by the drug developer company Acorda, drug named Ampyra, which is used in helping patients with multiple sclerosis walk, can also be beneficial for the patients suffering from strokes.

Companies: 
General: 

FDA Designated Breast Cancer Drug as 'Breakthrough Therapy’

FDA Designated Breast Cancer Drug as 'Breakthrough Therapy’

The researchers from the Revlon/UCLA Women's Cancer Research Program are investigating an experimental drug for the treatment of advanced breast cancer. This resulted in UCLA's Jonsson Comprehensive Cancer Center to receive a "breakthrough therapy" designation from the U. S. Food and Drug Administration.

Companies: 

Investigations Reveal Dangerous Practices at Compounding Pharmacies

Investigations Reveal Dangerous Practices at Compounding Pharmacies

Federal Regulators stated that they have discovered a large number of unsafe practices taking place at about 30 compounding pharmacies. It is the same type of facility that is behind the tainted drug causing deadly meningitis outbreak in previous year.

Companies: 
General: 

FDA Warns About the Harmful Effects from DMAA

FDA Warns About the Harmful Effects from DMAA

The Food and Drug Administration (FDA) is taking all the necessary measures to ensure that the dietary supplements containing a stimulant called dimethylamylamine (DMAA) are no longer being distributed and are not available for sale in the markets.

Companies: 
General: 

FDA Investigates Robotic Surgery

FDA Investigates Robotic Surgery

Development of multi-armed robot named as da Vinci was considered to be quite important in the field of surgery. However, things seem to be changing now and the same robot has been earning bad repute.

Companies: 
General: 

Nicotine Products Can Be Used For Longer Periods: FDA Approves

Nicotine Products Can Be Used For Longer Periods: FDA Approves

Initially it was 12 weeks time that was considered safe for using over the counter nicotine gums, patches and lozenges. But now on Monday, the Food and Drug Administration has approved an extended period for the same. FDA said that these over-the-counter products can be used for even a longer period of time but only with a doctor's approval. Well, any product that contains nicotine could prove to be potentially addictive but then after conducting several decades of researches these have been found carrying less risk for abuse or dependence.

Companies: 
General: 

Titan Soars by 54% after FDA Recommends Implant to Treat Painkiller Addiction

Titan Soars by 54% after FDA Recommends Implant to Treat Painkiller Addiction

Titan Pharmaceuticals Inc. soared by 54% after the Food and Drug Administration (FDA) recommended approval of experimental implant to treat painkiller addiction.

General: 

FDA Sends Letter to Pharmaxis

FDA Sends Letter to Pharmaxis

A biotechnology firm, Pharmaxis, has received a letter from the US Food and Drug Administration (FDA) regarding a drug that treats cystic fibrosis.

The drug is labeled Bronchitol. This letter is in response to the permission asked by Pharmaxis from the agency. The company wanted the drug to be used by cystic fibrosis patients aged six and above.

Companies: 
General: 

Pages